| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |